BioDelivery Sciences International, Inc.
Please contact Sales at: (212) 520-2765 or email PharmaNewsSales@informa.com
Latest From BioDelivery Sciences International, Inc.
Japan is aiming for the betterment of pharma R&D and medical services for rare disease patients by building a database connecting genome analysis data and clinical records. While several clinical studies are planned for the next couple of years, there are also concerns around the actual trickle-down of benefits to patients and data privacy.
Polyhexanide, from SIFI, could become the first approved treatment for acanthamoeba keratitis, while aflibercept could become the first biosimilar version of Eylea in the EU.
Taiho will pay Cullinan Oncology up to $405m for their joint venture and lead candidate for a form of lung cancer. Plus deals involving Zhaoke/Visus, AnGes/Eiger, Juniper/Helsinn, Peak Bio and more.
The VersiPD peritoneal system is the lightest, smallest and quietest dialysis system in the US, according to the company.
- Specialty Pharmaceuticals
- Other Names / Subsidiaries
- Arius Pharmaceuticals
- Arius Two Inc
- Bioral Nutrient Delivery LLC